Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Hanson Gifford
AddedMar 31, 2024
UpdatedMay 31, 2026
Hanson Gifford

Hanson Gifford

Co-Founder, Nexis Vision

CrunchbaseLinkedIn

Hanson Gifford's Career

Nexis Vision
Nexis Vision

Menlo Park, CA, US

Co-Founder
Half Moon Medical
Half Moon Medical

Menlo Park, CA, US

Board Member· Board
Foundry
Foundry

Menlo Park, CA, US

CEO· C-Suite · Management
Tangible Science
Tangible Science

Redwood City, CA, US

Board Member· Board
Reprieve Cardiovascular
Reprieve Cardiovascular

Milford, MA, US

Board Member· Board
Forsight Labs
Forsight Labs

Menlo Park, CA, US

Board Member· Board
Contego Medical
Contego Medical

Raleigh, NC, US

Board Member· Board
Allay Therapeutics
Allay Therapeutics

Menlo Park, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Hanson Gifford's Career

Nexis Vision
Nexis Vision
Pre-Seed$34.8M62007Menlo Park, CA, US
Co-Founder

Leadership at Nexis Vision

William LinkWilliam LinkBoard Member
Paul Bernard HaffeyPaul Bernard HaffeyCEO
Half Moon Medical
Half Moon Medical
Pre-Seed$3M172017Menlo Park, CA, US
Board Member· Board

Similar to Half Moon Medical

PolaresPolaresPalo Alto, CA, USMedical Devicesest. 2017PolaresPalo Alto, CA, US · est. 2017

Polares Medical: Innovating mitral valve regurgitation treatment with novel medical devices.

Series B · $65M30
MitraSpanMitraSpanBelmont, MA, USMedical Devicesest. 2012MitraSpanBelmont, MA, US · est. 2012

MitraSpan: Innovating minimally invasive heart treatments since 2012, based in Woburn, MA.

Seed · $2.7M30
Tau-Pnu MedicalTau-Pnu MedicalReston, VA, USMedical Devicesest. 2014Tau-Pnu MedicalReston, VA, US · est. 2014

TAU, a Virginia-based manufacturer, innovates minimally invasive catheter-based solutions for structural heart diseases.

Series B · $29.2M32
Opus Medical TherapiesOpus Medical TherapiesAtlanta, GA, USMedical Devicesest. 2014Opus Medical TherapiesAtlanta, GA, US · est. 2014

Opus Medical Therapies: Innovating transcatheter mitral and tricuspid valve replacements.

Seed · $4.7M11
Foundry
Foundry
Seed$3M261998Menlo Park, CA, US
CEO· C-Suite · Management

Leadership at Foundry

Allan WillAllan WillBoard Member
Andrew CleelandAndrew CleelandBoard Member
Mike ChalfenMike ChalfenBoard Member

Similar to Foundry

ExploraMed NC7ExploraMed NC7Mountain View, CA, USMedical Devicesest. 2014ExploraMed NC7Mountain View, CA, US · est. 2014

ExploraMed, a US-based medical tech incubator, accelerates the creation of innovative medical devices, meeting global health needs.

Series C · $132.6M30
Incube LabsIncube LabsSan Jose, CA, USMedical Devices, Therapeuticsest. 1995Incube LabsSan Jose, CA, US · est. 1995

InCube Labs: A life sciences lab pioneering medical breakthroughs for enhanced patient outcomes.

Series C · $30M75
Denali MedicalDenali MedicalBlaine, MN, USMedical Devicesest. 2006Denali MedicalBlaine, MN, US · est. 2006

Minnesota-based Denali Medical II, backed by NEA, incubates innovative medical devices and therapies, fostering successful business creation.

Series A · $6M6
Ontogen MedtechOntogen MedtechLisle, IL, USMedical Devicesest. 2021Ontogen MedtechLisle, IL, US · est. 2021

Ontogen Medtech: Expert medical device development and regulatory support for healthcare innovators.

Angel · $308k9
Tangible Science
Tangible Science
Pre-Seed$9.5M122011Redwood City, CA, US
Board Member· Board

Leadership at Tangible Science

Karen HavenstriteKaren HavenstriteCo-Founder
Victor McCrayVictor McCrayCo-Founder
Brandon FelkinsBrandon FelkinsCo-Founder
Richard KashnowRichard KashnowBoard Member
Reprieve Cardiovascular
Reprieve Cardiovascular
Series A$49.1M172018Milford, MA, US
Board Member· Board

Leadership at Reprieve Cardiovascular

Jim DillonJim DillonFounder
Mark PacynaMark PacynaCEO
Forsight Labs
Forsight Labs
Seed$69.4M52005Menlo Park, CA, US
Board Member· Board

Leadership at Forsight Labs

Kristen Angela MacfarlaneKristen Angela MacfarlaneCEO
Robin BellasRobin BellasBoard Member
Eugene De JuanEugene De JuanBoard Member
Contego Medical
Contego Medical

Raleigh, NC, US

Board Member· Board
Allay Therapeutics
Allay Therapeutics
Series C$118.9M562017Menlo Park, CA, US
Founder

Leadership at Allay Therapeutics

Adam GridleyAdam GridleyCEO
Josh MakowerJosh MakowerBoard Member
Nicole VitulloNicole VitulloBoard Member

Similar to Allay Therapeutics

Amalgent TherapeuticsAmalgent TherapeuticsChapel Hill, NC, USPain Medicationsest. 2020Amalgent TherapeuticsChapel Hill, NC, US · est. 2020

Amalgent Therapeutics: Innovating safer, effective analgesia alternatives to opioids since 2020.

Angel · $450k2
DoloromicsDoloromicsMenlo Park, CA, USBiomarkers, Pain Therapeuticsest. 2020DoloromicsMenlo Park, CA, US · est. 2020

Doloromics: A Dallas-based company innovating in pain therapeutics discovery and disease-specific solutions.

Seed · $7.7M7

Hanson Gifford's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Hanson Gifford

Bill MortimoreBill MortimoreCo-Founder · Project FoundryRichard ChangRichard ChangCEO · NewFoundryJody MaddenJody MaddenBoard Member · AccessoAlon KrashinskyAlon KrashinskyCo-Founder · LightshipSultan MeghjiSultan MeghjiFounder · RevioBrian MullinsBrian MullinsFounder & CEO · Daqri